ExploreInsights

IN8Bio

0 Followers

About

IN8bio, Inc. (“IN8bio”) is a clinical-stage biotechnology company focused on developing novel therapies for the treatment of cancers by employing allogeneic, autologous and genetically modified gamma-delta T cells.

Lawrence Lamb
EVP, Chief Scientific Officer & Co-Founder
Pat McCall
CFO
Melissa Beelen
VP, Clinical Operations
Kate Rochlin
VP, Operations & Innovation
Lou Vaickus
Interim Chief Medical Officer

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.